Skip to Main Content

KYNMOBI®
Savings Program

Two ways to save on your prescription

Image of the KYNMOBI Copay Savings Card

Patients may be eligible for the KYNMOBI copay savings card

Option one icon

Eligible commercially insured patients may pay as little as
$15 per 30-count carton with the KYNMOBI Copay Savings Card

Option two icon

Eligible uninsured cash-paying patients may pay as little as
$195 per 30-count carton with the KYNMOBI Copay Savings Card

No annual cap. Up to 5 cartons per month.

Eligibility requirements and restrictions apply. Individual copay amounts may vary. A maximum benefit limit also applies.
For details, see the KYNMOBI Savings Program Terms and Conditions below.

Already have your copay card?
Activate it here

Lost your copay card or need other help?

Request a replacement card or get additional assistance with activating your card by calling
at 1-844-KYNMOBI (1-844-596-6624), Monday through Friday, 8 AM–8 PM ET.

KYNMOBI® (apomorphine HCl) Copay Savings Card Terms and Conditions

By using this card, you acknowledge that you currently meet the following eligibility requirements:

  • You are 18 years of age or older.
  • You have a valid prescription for KYNMOBI.
  • You are not enrolled in any state or federal healthcare program, including, but not limited to, Medicare (including Medicare Advantage), Medicaid (including managed Medicaid plans), Medigap, VA, DOD, or TRICARE. In addition, you are not Medicare-eligible and enrolled in an employer-sponsored health plan or prescription drug benefit program for retirees.

Additional Terms and Conditions Include:

  • The offer applies only to prescriptions filled before the program expires or terminates.
  • The copay prescription shall not be submitted for reimbursement to any federal or state healthcare program, including Medicare (including Medicare Advantage), Medicaid (including managed Medicaid plans), Medigap, VA, DOD, TRICARE, or an employer-sponsored health plan or prescription drug benefit program for Medicare-eligible retirees.
  • Individual copay amounts may vary. Eligible patients with commercial insurance may pay as little as $15 per 30-count carton. Eligible cash paying patients may pay as little as $195 per 30-count carton. A maximum benefit limit may also apply. If the patient’s total out-of-pocket pharmacy bill exceeds the cap established by Sunovion, the patient will be responsible for the additional balance. Patients should confirm their out-of-pocket costs.
  • This program is not health insurance.
  • The amount of the benefit will not exceed your out-of-pocket expenses.
  • You must deduct the value of the savings received under this program from any reimbursement request submitted to your insurance plan, either directly or on your behalf.
  • Offer limited to one per person and may not be used with any other offer.
  • A minimum patient requirement for participation in the program is an activated Program ID number.
  • Only an original (no copies) or printout of the copay savings card must be presented to participating pharmacies.
  • For California and Massachusetts residents, benefits pursuant to this copay savings card will terminate automatically upon the introduction of a therapeutically equivalent product.
  • Offer valid only in the United States and Puerto Rico. Void where prohibited by law, taxed, or restricted.
  • Certain information related to your use of the copay savings card may be collected, analyzed, and shared with Sunovion for market research and other purposes related to assess Sunovion’s programs. Information shared with Sunovion will be aggregated and deidentified; it will be combined with other data related to other copay savings card redemptions and will not identify you.

This offer is not transferable and may not be sold, purchased or traded, or offered for sale, purchase, or trade. The offer has no cash value and may not be combined with any other discount, coupon, rebate, free trial, or similar offer for the specified prescription. The offer is intended to comply with all applicable laws and regulations, including, without limitation, the federal Anti-Kickback Statute, its implementing regulations, and agency guidance interpreting the federal Anti-Kickback Statute; the government pricing laws; and all other applicable laws.

To the Patient: You must present this copay savings card to the pharmacist along with your valid prescription to participate in this program. If you have any questions regarding your copay savings card eligibility or benefits, or if you wish to discontinue your participation, call KYNMOBI® KYNNECT. By using this copay savings card, you are certifying that you understand the enclosed program rules, regulations, and terms and conditions; you are eligible to participate in this program, including that you are not enrolled in any federal or state healthcare program; you have not submitted and will not submit a claim for reimbursement to, or otherwise seek payment from, any federal, state, or other governmental program for this prescription or where otherwise prohibited by law in your state; you will comply with any obligations or requirements imposed by your insurance plan; and you will otherwise comply with the terms mentioned herein.

To the Pharmacist: When you use this copay savings card, you are certifying that you have appropriately inquired regarding the patient’s insurance coverage and have not submitted and will not submit a claim for reimbursement to, or otherwise seek payment from, any federal or state healthcare program for this prescription.

  • Submit transaction to RxC Acquisition Company d/b/a RxCrossroads by McKesson using BIN #610524.
  • If primary commercial prescription exists, input card information as secondary coverage and transmit using the COB segment of the NCPDP transaction. Applicable discounts will be displayed in the transaction response.
  • Acceptance of this copay savings card and your submission of claims to the program are subject to the LoyaltyScript® program Terms and Conditions posted at www.mckesson.com/mprstnc.
  • The LoyaltyScript® Card is not valid for use with any other prescription drug discount or cash cards for KYNMOBI. Claims submitted utilizing the program are subject to audit or validation.
  • Patient is not eligible if prescriptions are paid in part or full by any state or federally funded healthcare programs, including but not limited to Medicare (including Medicare Advantage) or Medicaid (including managed Medicaid plans), Medigap, VA, DOD, TRICARE, or where prohibited by law. In addition, patients may not use the offer if they are Medicare-eligible and enrolled in an employer-sponsored health plan or prescription drug benefit program for retirees.
  • For questions regarding setup, claim transmission, patient eligibility, or other issues, call KYNMOBI® KYNNECT.

Sunovion reserves the right to rescind, revoke, or amend this offer at any time without notice.

IMPORTANT SAFETY INFORMATION AND INDICATION FOR KYNMOBI (apomorphine HCI) SUBLINGUAL FILM

Do not take KYNMOBI if you are taking certain medicines to treat nausea called 5HT3 antagonists, including ondansetron, granisetron, dolasetron, palonosetron, and alosetron. People taking ondansetron together with apomorphine, the active ingredient in KYNMOBI, have had very low blood pressure and lost consciousness or "blacked out."

Do not use KYNMOBI if you are allergic to apomorphine hydrochloride or to any of the ingredients in KYNMOBI. KYNMOBI also contains a sulfite called sodium metabisulfite. Sulfites can cause severe, life‐threatening allergic reactions in some people. An allergy to sulfites is not the same as an allergy to sulfa. People with asthma are more likely to be allergic to sulfites. Call your healthcare provider if you have hives, itching, rash, swelling of the lips, tongue and mouth, redness of your face (flushing), throat tightness, trouble breathing or swallowing.

Before starting KYNMOBI, tell your healthcare provider:

About all of your medical conditions, including if you:

  • have difficulty staying awake during the daytime
  • have liver problems
  • have dizziness
  • have kidney problems
  • have fainting spells
  • have heart problems
  • have low blood pressure
  • have had a stroke or other brain problems
  • have asthma
  • have a mental problem called a major psychotic disorder
  • are allergic to any medicines containing sulfites
  • drink alcohol
  • are pregnant or plan to become pregnant. It is not known if KYNMOBI will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if KYNMOBI passes into your breast milk. You and your healthcare provider should decide if you will take KYNMOBI or breastfeed.

Tell your healthcare provider about all the medicines you take, including:

  • prescription medicines
  • over-the-counter medicines
  • vitamins
  • herbal supplements

KYNMOBI may affect the way other medicines work, and other medicines can affect how KYNMOBI works. Taking KYNMOBI with other medicines may cause serious side effects.
If you take nitroglycerin under your tongue (sublingual) while using KYNMOBI, your blood pressure may decrease and cause dizziness. You should lie down before and after taking sublingual nitroglycerin.

KYNMOBI can cause serious side effects, including:

  • nausea and vomiting. Nausea is a common side effect of KYNMOBI. Nausea and vomiting can happen with KYNMOBI. Your healthcare provider may prescribe a medicine called an antiemetic, such as trimethobenzamide to help prevent nausea and vomiting. If trimethobenzamide is prescribed, talk to your healthcare provider about how long you should remain on this medicine.
  • sleepiness or falling asleep during the day. Sleepiness is a serious, and common side effect of KYNMOBI. Some people treated with KYNMOBI may get sleepy during the day or fall asleep without warning while doing everyday activities such as talking, eating, or driving a car.
  • dizziness. Dizziness is a serious, and common side effect of KYNMOBI. KYNMOBI may lower blood pressure and cause dizziness. Dizziness can happen when KYNMOBI treatment is started or when the KYNMOBI dose is increased. Do not get up too fast from sitting or after lying down, especially if you have been sitting or lying down for a long period of time.
  • mouth (oral) irritation. Mouth (oral) irritation is a common side effect of KYNMOBI. You should call your healthcare provider if you develop any of these signs or symptoms:
    • redness
    • mouth sores (ulceration)
    • dryness of the mouth, lips or tongue
    • swelling
    • pain
    • pain with swallowing
  • falls. The changes that can happen with PD, and the effects of some PD medicines, can increase the risk of falling. KYNMOBI may also increase your risk of falling.
  • hallucinations or psychotic-like behavior. KYNMOBI may cause or make psychotic-like behavior worse including hallucinations (seeing or hearing things that are not real), confusion, excessive suspicion, aggressive behavior, agitation, delusional beliefs (believing things that are not real), and disorganized thinking.
  • low red blood cells (hemolytic anemia). Tell your healthcare provider if you have any of the following signs or symptoms:
    • you become pale
    • skin or eyes look yellow
    • chest pain
    • dizziness
    • fever
    • dark-colored urine
    • fast heartbeat
    • feel more tired or weaker than usual
    • shortness of breath or trouble breathing
    • confusion
  • strong (intense) urges. Some people with PD have reported new or strong uncontrollable urges to gamble, increased sexual urges, increased urges to spend money (compulsive shopping), and other intense urges, while taking PD medicines, including KYNMOBI. If you or your family members notice that you have strong urges, talk to your healthcare provider. The strong urges may go away if your KYNMOBI dose is lowered or stopped.
  • high fever and confusion. KYNMOBI may cause a problem that can happen in people who suddenly lower their dose, stop using, or change their dose of KYNMOBI. Symptoms include:
    • very high fever
    • confusion
    • stiff muscles
    • changes in breathing and heartbeat

    Do not stop taking KYNMOBI or change your dose unless you are told to do so by your healthcare provider.

  • heart problems. If you have shortness of breath, fast heartbeat, chest pain, or feel like you are going to pass out (faint) while taking KYNMOBI, call your healthcare provider or get emergency help right away.
  • tissue changes (fibrotic complications). Some people have had changes in the tissues of their pelvis, lungs, and heart valves when taking medicines called nonergot derived dopamine agonists like KYNMOBI.
  • prolonged painful erections (priapism). KYNMOBI may cause prolonged, painful erections in some people. If you have a prolonged and painful erection, you should call your healthcare provider or go to the nearest hospital emergency room right away.

The most common side effects of KYNMOBI include:

  • nausea
  • dizziness
  • sleepiness
  • mouth swelling, pain, or sores

INDICATION

KYNMOBI® (apomorphine HCl) sublingual film is a prescription medicine used to treat short-term (acute), intermittent “off” episodes in people with Parkinson’s disease (PD).

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information, please see the KYNMOBI Patient Information, full Prescribing Information, and Instructions for Use.